Phase II trial of dose dense docetaxel followed by FEC100 as neoadjuvant chemotherapy in patients with operable breast cancer.
Am J Clin Oncol
; 33(6): 544-9, 2010 Dec.
Article
in En
| MEDLINE
| ID: mdl-20042972
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoadjuvant Therapy
/
Neoplasm Recurrence, Local
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Year:
2010
Type:
Article